amyotrophic lateral sclerosis therapeutics (Aestus Therapeutics/ALS TDI)

N/A

Report date: 2025/03/18 18:07:51
NME

Base Information

Drug Nameamyotrophic lateral sclerosis therapeutics (Aestus Therapeutics/ALS TDI)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAestus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesALS Therapy Development Foundation IncAestus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A